Corporate News 09-Feb-24
Biocon receives Complete Response Letter for Biologics License Application
From USFDA
Biocon announced that the U.S. Food and Drug Administration (US FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for bBevacizumab. The CRL did not identify any outstanding scientific issues on the dossier and informs the need for the completion of a pre-approval inspection of the bBevacizumab manufacturing facility.
Previous News
Biocon’s Andhra Pradesh facility gets 3 USFDA observations
( Hot Pursuit - 15-Jun-24 16:32 )
Biocon
( Results - Analysis 17-May-24 10:41 )
Biocon
( Results - Analysis 13-Nov-23 12:15 )
Biocon Ltd rises for third consecutive session
( Hot Pursuit - 24-Apr-24 13:05 )
Biocon Ltd soars 1.22%, rises for fifth straight session
( Hot Pursuit - 27-Mar-24 13:00 )
Biocon Ltd eases for fifth straight session
( Hot Pursuit - 25-Oct-23 13:35 )
Biocon signs exclusive licensing and supply agreement with Handok
( Corporate News - 24-May-24 09:06 )
Biocon Ltd spurts 0.71%, rises for fifth straight session
( Hot Pursuit - 19-Jun-23 13:00 )
Eris Lifesciences avails term loan of Rs 280 cr from Citi Bank
( Corporate News - 09-Nov-23 09:15 )
Biocon
( Results - Analysis 28-Jul-22 10:30 )
Biocon Ltd soars 0.15%, up for fifth straight session
( Hot Pursuit - 20-Jul-23 13:00 )
Other Stories
Share India Securities allots 16.92 lakh equity shares on conversion of warrants
06-Jul-24 13:11
Tinna Trade raises Rs 49 cr to fund its growth plans
06-Jul-24 11:10
Integra Essentia announces merger with G G Engineering
06-Jul-24 11:05
Ugro Capital to raise Rs 75 cr via NCD issuance
06-Jul-24 10:58
Board of D.P. Abhushan approves preferential allotment of shares and warrants
06-Jul-24 10:50
Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
06-Jul-24 10:49
High Energy Batteries (India) to discuss results
06-Jul-24 10:29
Havells India schedules board meeting
06-Jul-24 10:29
Axis Bank announces board meeting date
06-Jul-24 10:29
Mastek to conduct board meeting
06-Jul-24 10:29
Back
Top
